Who has poor insight, my patient suffering from schizophrenia or myself?

[1]  J. Luykx.  The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders , 2022, European Neuropsychopharmacology.

[2]  A. Tanskanen,et al.  Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials , 2022, JAMA psychiatry.

[3]  G. Remington,et al.  Cognitive discrepancies, motivation and subjective well-being in people with schizophrenia , 2021, Schizophrenia Research: Cognition.

[4]  D. Roe,et al.  Conceptualization and Study of Antipsychotic Medication Use: From Adherence to Patterns of Use. , 2021, Psychiatric services.

[5]  J. Moncrieff,et al.  Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review , 2020, Schizophrenia Research.

[6]  M. Davidson.  The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia , 2018, Dialogues in clinical neuroscience.

[7]  G. Remington,et al.  Values in First-Episode Schizophrenia , 2015, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[8]  D. Wiersma,et al.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. , 2013, JAMA psychiatry.

[9]  John M. Davis,et al.  Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis , 2012, The Lancet.

[10]  M. Harrow,et al.  Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study , 2012, Psychological Medicine.

[11]  G. Bartzokis,et al.  Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. , 2001, The American journal of psychiatry.

[12]  OUP accepted manuscript , 2021, Schizophrenia Bulletin.